FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/06/2024
Back to search
Official data from USPTO
ICAMUN BIOTHERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079352690Class
5, 10, 35, 42, 44
Filing
79352690
Registration
7318237
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
06/06/2024
Trademark type
Combined
Nice classes
5, 10, 35, 42, 44
Filing date
06/02/2022
Registration date
03/05/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/05/2024
Last transaction
03/05/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Jiangsu Free Trade Zone, CN
Examiner
STANWOOD, STEPHEN D
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of, in a gradient from purple at the left to blue at the right, the stylized phrase "ICAMUNO BIOTHERAPEUTICS", with "ICAMUNO" above "BIOTHERAPEUTICS". The "O" in "ICAMUNO" is formed by a DNA double-helix design with one blue strand and one purple strand. All instances of the color white represent background or transparent areas only and are not a feature of the mark.
Holders and representatives
Holders
Suzhou Aikailiyuan Biotech Ltd.
Representatives
Michael T. Smith Birch Stewart Kolasch & Birch LLP
Technical classification
Nice Classes
Class 5Class 10Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations for medical purposes for the treatment of cardiovascular diseases and disordersophthalmic diseases and disordersrespiratory diseases and disordershyperlipidemiahypertensionpulmonary hypertensioncancerdiabetesinfectious diseaseshypercholesterolemiaallergiesinflammationpain; chemico-pharmaceutical preparations for the treatment of cardiovascular diseases and disordersophthalmic diseases and disordersrespiratory diseases and disordershyperlipidemiahypertensionpulmonary hypertensioncancerdiabetesinfectious diseaseshypercholesterolemiaallergiesinflammationpain; pharmaceutical preparations for the treatment of cardiovascular diseases and disordersophthalmic diseases and disordersrespiratory diseases and disordershyperlipidemiahypertensionpulmonary hypertensioncancerdiabetesinfectious diseaseshypercholesterolemiaallergiesinflammationpain; human vaccine preparations; antibiotics for human use; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; dietetic preparations adapted for medical purposes; depuratives for the body; Veterinary diagnostic reagents; veterinary vaccines; anti-infective products for veterinary use; veterinary preparationspain relief medication; Enzymes for veterinary purposes; biocides; babies' diaper-pants; cotton for medical purposes; medicinal preparations to facilitate teething; diapers for pets
Class 10
Medical apparatus and instruments for monitoring vital signsblood properties and respiratory events; surgical apparatus and instruments for medical use; surgical apparatus and instruments for dental use; radiological apparatus for medical purposes; sanitary masks; protective masks for medical purposes; babies' bottles; Intra-uterine contraceptive devices; diaphragms for contraception; artificial heart valves; orthopedic apparatus for diagnostic and therapeutic use; suture materials
Class 35
Advertising services; business consulting services; marketing services; personnel management consultancy; updating and maintenance of data in computer databases; accounting services; rental of vending machines; retail drug store services; wholesale drug store services; wholesale and retail store services featuring medical supplies
Class 42
Scientific research and development; chemical research; development of pharmaceutical preparations and medicines; biomedical research services; medical research services; biotechnology research; pharmaceutical drug development services; pharmaceutical drug research services; drug testing servicesdrug screening for scientific research purposes; computer software design
Class 44
Medical screening; provision of medical information; health counseling; health care; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; medical consultations; telemedicine services; mental health therapy services; physical therapy in the nature of movement therapy; veterinary specialty services providing advanced medicaldiagnostic or surgical services for animals
Publications
History of USPTO decisions and trademark events.
23 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/05/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
03/05/2024
GPNX
NOTIFICATION PROCESSED BY IB
12/19/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/19/2023
PUBO
PUBLISHED FOR OPPOSITION
12/19/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/29/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/29/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/29/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/08/2023
RFNT
REFUSAL PROCESSED BY IB
05/31/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/10/2023
RFRR
REFUSAL PROCESSED BY MPU
05/10/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/25/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/21/2023
CPRA
PRIORITY ACTION WRITTEN
03/20/2023
DOCK
ASSIGNED TO EXAMINER
03/20/2023
MAFR
APPLICATION FILING RECEIPT MAILED
10/21/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/17/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/13/2022
Continuous trademark protection
Get notified about every new filing that threatens ICAMUN BIOTHERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.